Abstract
Factors limiting the therapeutic application of neurotrophins to neurodegenerative diseases include poor stability and CNS penetration. Moreover, certain neurotrophin effects, such as promotion of neuronal death via interaction with the p75NTR receptor, might further limit their application. We have proposed that development of small molecule mimetics of neurotrophins might serve to overcome these limitations. In previous work, our laboratory established the proof-of-principle that mimetics of specific nerve growth factor (NGF) domains could prevent neuronal death. Peptidomimetics of the loop 1 domain prevent death via p75NTR-dependent signaling and peptidomimetics of the loop 4 domain prevent death via Trk-related signaling. In current work we are designing pharmacophore queries corresponding to loop domains 1 or 4 that incorporate features of the NGF crystal structure along with features derived from peptidomimetic structure-activity-relationships. Screening of in silico databases containing non-peptide, small molecules has identified a number of candidate NGF domain mimetics. Preliminary assessment of these compounds using neurotrophin bioassays indicates that several are capable of preventing neuronal death. Ongoing studies will determine whether these compounds act via p75NTR or Trk receptors.
Article PDF
Similar content being viewed by others
References
Bergmann I., Reiter R., Toyka K. V., and Koltzenburg M. (1998) Nerve growth factor evokes hyperalgesia in mice lacking the low-affinity neurotrophin receptor p75. Neurosci. Lett. 255, 87–90.
Braan A. B., Tcherpakov M., Williams I. M., Futerman A. H., and Fainzilber M. (2002) Nerve growth factor-induced p75-mediated death of cultured hippocampal neurons is age-dependent and transduced through ceramide generated by neural sphingomyelinase. J. Biol. Chem. 277, 9812–9818.
Casaccia-Bonnefil P., Carter B. D., Dobrowsky R. T., and Chao M. V. (1996) Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383, 716–719.
DeFreitas M. F., McQuillen P. S., and Shatz C. J. (2001) A novel p75NTR signaling pathway promotes survival, not death, of immunopurified neocortical subplate neurons. J. Neurosci. 21, 5121–5129.
Dobrowsky R. T. and Carter B. D. (2000) p75 neurotrophin receptor signaling: mechanisms for neurotrophic modulation of cell stress? J. Neurosci. Res. 61, 237–243.
Fahnestock M., Michalski B., Xu B., and Coughlin M. D. (2001) The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer’s disease. Mol. Cell. Neurosci. 18, 210–220.
Frade J. M., Rodriguez-Tebar A., and Barde Y. A. (1996) Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383, 166–168.
Goslin K., Asmussen H., and Banker G. (1998) Rat hippocampal neurons in low density culture, in Culturing Nerve Cells (Banker G. and Goslin K., eds.), MIT Press, Cambridge, MA, pp. 339–370.
Hempstead B. L. (2002) The many faces of p75NTR. Curr. Opin. Neurobiol. 12, 260–267.
Kawasumi M., Hashimoto Y., Chiba T., et al. (2002) Molecular mechanisms for neuronal cell death by Alzheimer’s amyloid precursor protein-relevant insults. Neurosignals 11, 236–250.
Khursigara G., Bertin J., Yano H., Moffett H., DiStefano P.S., and Chao M. V. (2001) A prosurvival function for the p75 receptor death domain mediated via the caspase recruitment domain receptor-interacting protein 2. J. Neurosci. 21, 5854–5863.
Lee R., Kermani P., Teng K., and Hempstead B. (2001) Regulation of cell survival by secreted proneurotrophins. Science 294, 1945–1948.
Longo F. M., Manthorpe M., Xie Y. M., and Varon S. (1997) Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism. J. Neurosci. Res. 48, 1–17.
Maliartchouk S., Debeir T., Beglova N., Cuello A. C., Gehring K., and Saragovi H. U. (2000) Genuine monovalent ligands of TrkA nerve growth factor receptors reveal a novel pharmacological mechanism of action. J. Biol. Chem. 275, 9946–9956.
Mamidipudi V. and Wooten M. W. (2002) Dual role for p75NTR signaling in survival and death: can intracellular mediators provide an explanation? J. Neurosci. Res. 68, 373–384.
Massa S. M., Xie Y., and Longo F. M. (2002) Alzheimer’s therapeutics: neurotrophin small molecule mimetics. J. Mol. Neurosci. 19, 107–111.
McDonald N. Q. and Chao M. V. (1995) Structural determinants of neurotrophin action. J. Biol. Chem. 270, 19,669–19,672.
Poduslo J. F. and Curran G. L. (1996) Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Mol. Brain Res. 36, 280–286.
Rabizadeh S. and Bredesen D. E. (2003) Ten years on: mediation of cell death by the common neurotrophin receptor p75NTR. Cytokine Growth Factor Rev. 14, 224–239.
Roux P. P., Bhakar A. L., Kennedy T. E., and Barker P. A. (2001) The p75 neurotrophin receptor activates Akt (Protein Kinase B) through a phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 276, 23,097–23,104.
Savage M. J., Lin Y.-G., Ciallella J. R., Flood D. G., and Scott R. W. (2002) Activation of c-Jun N-terminal kinase and p38 in an Alzheimer’s disease model is associated with amyloid deposition. J. Neurosci. 22, 3376–3385.
Sofroniew M. V., Howe C. L., and Mobley W. C. (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24, 1217–1281.
Tuszynski M. H. (2002) Growth-factor gene therapy for neurodegenerative disorders. Lancet Neurol. 1, 51–57.
Xie Y., Tisi M. A., Yeo T. T., and Longo F. M. (2000) NGF loop 4 dimeric mimetics activate ERK and AKT and prevent neuronal death. J. Biol. Chem. 275, 29,868–29,874.
Yaar M., Zhai S., Fines R. E., Eisenhauer P. B., Arble B. L., Stewart K. B., and Gilchrest B. A. (2002) Amyloid β binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Massa, S.M., Xie, Y. & Longo, F.M. Alzheimer’s therapeutics. J Mol Neurosci 20, 323–326 (2003). https://doi.org/10.1385/JMN:20:3:323
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:20:3:323